BlogZone Get the app
Health

Common blood pressure drug could make cancer therapy far more powerful

ScienceDaily Health 11 Jul 2026 1 views

Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials after showing strong immune-boosting and anticancer effects in preclinical studies.

BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.

Read the full story at ScienceDaily Health →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Health

Health

I'm burnt out and feel forgotten as a young carer

Min, 16, says people do not always understand her sacrifices and how valuable support is.

BBC Health · 2 hours ago
Health

Which antidepressants are the most effective?

Antidepressant escitalopram performed best at keeping depression symptoms away in a study involving nearly 10,000 people. But experts say the differences between medications were small.

BBC Health · 3 hours ago
Health

Common forever chemicals linked to nearly double the rate of aggressive breast cancer

An NIH study found that women with high levels of two common “forever chemicals” had up to 93% higher rates of an aggressive form of breast cancer. The discovery raises concerns about the potential he

ScienceDaily Health · 6 hours ago